Acute lung injury: Can the fibrocyte of today turn into the fibroguide of the future?

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 300-301

  Dik, Willem A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COLLAGEN; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROTEIN C; SECONDARY LYMPHOID TISSUE CHEMOKINE; VON WILLEBRAND FACTOR;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; CELL ACTIVITY; CELL DIVISION; EDITORIAL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; IMMUNE RESPONSE; LUNG FIBROSIS; LUNG FLUID; LUNG LAVAGE; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TISSUE REPAIR;

ACUTE LUNG INJURY; FEMALE; HUMANS; MALE; PULMONARY ALVEOLI;

EID: 84055184197     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318236e7c8     Document Type: Editorial

References (17)

1. Mutsaers SE, Bishop JE, McGrouther G, et al: Mechanisms of tissue repair: From wound healing to fibrosis. Int J Biochem Cell Biol 1997; 29:5-17
2. Iwano M, Plieth D, Danoff TM, et al: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350
3. Strutz F, Okada H, Lo CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393-405
4. Bucala R, Spiegel LA, Chesney J, et al: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1:71-81
5. Reilkoff RA, Bucala R, Herzog EL: Fibrocytes: Emerging effector cells in chronic inflammation. Nat Rev Immunol 2011; 11:427-435
6. Douglas RS, Afifiyan NF, Hwang CJ, et al: Increased generation of fibrocytes in thyroidassociated ophthalmopathy. J Clin Endocrinol Metab 2010; 95:430-438
7. Sakai N, Wada T, Matsushima K, et al: The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens 2008; 26:780-790
8. Schmidt M, Sun G, Stacey MA, et al: Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171:380-389
9. Yang L, Scott PG, Giuffre J, et al: Peripheral blood fibrocytes from burn patients: Identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002; 82:1183-1192
10. Phillips RJ, Burdick MD, Hong K, et al: Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114:438-446
11. Moeller A, Gilpin SE, Ask K, et al: Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179:588-594
12. Marshall RP, Bellingan G, Webb S, et al: Fibroproliferation occurs early in the acute respiratory distress syndrome and impacts on outcome. Am J Respir Crit Care Med 2000; 162:1783-1788
13. Wheeler AP, Bernard GR: Acute lung injury and the acute respiratory distress syndrome: A clinical review. Lancet 2007; 369: 1553-1564
14. Quesnel C, Nardelli L, Piednoir P, et al: Alveolar fibroblasts in acute lung injury: Biological behaviour and clinical relevance. Eur Respir J 2010; 35:1312-1321
15. Quesnel C, Piednoir P, Gelly J, et al: Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury. Crit Care Med 2012; 40:21-28
16. Pilling D, Fan T, Huang D, et al: Identification of markers that distinguish monocytederived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One 2009; 4:e7475
17. Ware LB: Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 2005; 33(Suppl):S217-S222